Philip Kiely

1.3k total citations
46 papers, 972 citations indexed

About

Philip Kiely is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Philip Kiely has authored 46 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Hepatology and 20 papers in Infectious Diseases. Recurrent topics in Philip Kiely's work include Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (20 papers) and Mosquito-borne diseases and control (8 papers). Philip Kiely is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (20 papers) and Mosquito-borne diseases and control (8 papers). Philip Kiely collaborates with scholars based in Australia, Netherlands and Germany. Philip Kiely's co-authors include Clive R. Seed, A. J. Keller, Veronica C. Hoad, Susan Parker, Erica M. Wood, Wayne Bolton, H Kelly, J Leydon, William J. Maskill and R. Hammond and has published in prestigious journals such as The Medical Journal of Australia, Transfusion and Viruses.

In The Last Decade

Philip Kiely

41 papers receiving 947 citations

Peers

Countries citing papers authored by Philip Kiely

Since Specialization

Citations

This map shows the geographic impact of Philip Kiely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Kiely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Kiely more than expected).

Fields of papers citing papers by Philip Kiely

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Kiely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Kiely. The network helps show where Philip Kiely may publish in the future.

Co-authorship network of co-authors of Philip Kiely

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Kiely. A scholar is included among the top collaborators of Philip Kiely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Kiely. Philip Kiely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Removal of UK‐donor deferral for variant Creutzfeldt–Jakob disease: A large donation gain in Australia 2023 ·Vox Sanguinis ·Veronica C. Hoad, Clive R. Seed, Philip Kiely, (unknown), Hamish McManus, Matthew Law, John Kaldor, Iain B. Gosbell	2
2	Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review 2022 ·Transfusion Medicine and Hemotherapy ·Philip Kiely, Veronica C. Hoad, Clive R. Seed, Iain B. Gosbell	3
3	Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. “Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country” [Transfus Med Hemother. 2019 Apr;46(2):104–10] 2019 ·Transfusion Medicine and Hemotherapy ·(unknown), (unknown), Veronica C. Hoad, Philip Kiely, Michael Watson, Clive R. Seed	3
4	Confirming transfusion‐transmitted viral infections in the molecular age: time to get back to the basic definition of infection for hemovigilance 2019 ·Transfusion ·Veronica C. Hoad, (unknown), Clive R. Seed, Philip Kiely, Iain B. Gosbell	0
5	Blood safety assessment of hepatitis A outbreak linked to frozen pomegranate arils: are foodborne outbreaks an emerging blood safety risk? 2019 ·Transfusion ·(unknown), Veronica C. Hoad, Philip Kiely, Clive R. Seed, Iain B. Gosbell	0
6	Anti‐HCV immunoblot indeterminate results in blood donors: non‐specific reactivity or past exposure to HCV? 2017 ·Vox Sanguinis ·Philip Kiely, (unknown)	3
7	Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk 2017 ·Transfusion Medicine Reviews ·Philip Kiely, Manoj Gambhir, Allen Cheng, Zoe McQuilten, Clive R. Seed, Erica M. Wood	23
8	No evidence of a significantly increased risk of transfusion‐transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12‐month deferral for men who have had sex with men (CME) 2010 ·Transfusion ·Clive R. Seed, Philip Kiely, Matthew Law, A. J. Keller	52
9	Analysis of sample‐to‐cutoff ratios on chemiluminescent immunoassays used for blood donor screening highlights the need for serologic confirmatory testing 2010 ·Transfusion ·Philip Kiely, (unknown), Susan Parker, (unknown)	25
10	The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia 2009 ·Transfusion ·Clive R. Seed, Philip Kiely, Catherine A. Hyland, A. J. Keller	40
11	An international quality control programme for PRISM chemiluminescent immunoassays in blood service and blood product laboratories 2009 ·Vox Sanguinis ·(unknown), Wayne Dimech, Philip Kiely, (unknown), (unknown), (unknown), Elizabeth M. Dax	10
12	Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA 2007 ·Transfusion ·(unknown), (unknown), Clive R. Seed, Philip Kiely, Bruno D’Agostino, A. J. Keller	60
13	Ex vivo monitoring of human cytomegalovirus‐specific CD8+ T‐cell responses using QuantiFERON^®‐CMV 2007 ·Transplant Infectious Disease ·Susan Walker, Chrysa Fazou, Tania Crough, Rhonda Holdsworth, Philip Kiely, (unknown), Scott C. Bell, (unknown), K. McNeil, Samuel L. Jones, Rajiv Khanna	132
14	Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus 2005 ·Internal Medicine Journal ·Clive R. Seed, Philip Kiely, A. J. Keller	72
15	The significance of third‐generation HCV RIBA‐indeterminate, RNA‐negative results in voluntary blood donors screened with sequential third‐generation immunoassays 2004 ·Transfusion ·Philip Kiely, (unknown), Susan Parker, (unknown)	32
16	Analysis of voluntary blood donors with biologic false reactivity on chemiluminescent immunoassays and implications for donor management 2003 ·Transfusion ·Philip Kiely, (unknown), (unknown)	25
17	Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays 2003 ·Transfusion ·Clive R. Seed, (unknown), Wayne Bolton, Philip Kiely, Susan Parker, (unknown)	36
18	Follow‐up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests 2003 ·Vox Sanguinis ·Catherine A. Hyland, Clive R. Seed, Philip Kiely, Susan Parker, (unknown), Wayne Bolton	16
19	Results of HCV screening of volunteer blood donors with a chemiluminescent immunoassay and a second‐ or third‐generation EIA: overlap of false‐positive reactivity and its impact on donor management 2000 ·Transfusion ·Philip Kiely, D. V. Wilson	10
20	Exposure to hepatitis A virus among blood donors, injecting drug users and prison entrants in Victoria 1997 ·Journal of Viral Hepatitis ·Nick Crofts, Gregory S. Cooper, (unknown), Philip Kiely, Patrick Coghlan, (unknown), Jane S. Hocking	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact